Takeda to Use Zinfandel TOMM40 Biomarker Assay for Alzheimer's Drug Study

Takeda has taken an exclusive, worldwide license for the use of Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.